Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
54 / 178
Position in country
1313 / 7387
Return on Assets, %
5.7
2.4
Net income margin, %
3.7
1.5
EBITDA margin, %
5.4
4.6
Debt to Equity, %
45.2
35.4
Intangible assets and goodwill, %
5.1
1.8
Revenue CAGR 3Y, %
6.9
8.3
Total Equity change 1Y, %
5.8
0
Revenue Y, % chg
0.9
1.5
P/E
7.1
17.4
P/BV
0.8
1.2
P/S
0.3
0.6
EV/S
0.5
0.8
EV/EBITDA
8.6
8.6
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
34.7
20.7
Forward P/E
6.9
13.1
Dividend Yield, %
4.2
2.7
Forward Dividend Yield, %
0.5
0.5
Expected dividend per share
0.1
0.1
Payout Ratio, %
30
30.7
Competitors
Ranks
-
China National Medicines Corp Ltd
00%
-
China National Accord Medicines Corp Ltd
00%
-
Tibet Rhodiola Pharmaceutical Holding Co
00%
-
Huadong Medicine Co Ltd
00%
-
Qingdao Baheal Medical Inc
00%
-
Jointown Pharmaceutical Group Co Ltd
00%
-
Sinopharm Group Co Ltd
00%
-
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
00%
-
Shanghai Pharmaceuticals Holding Co Ltd
00%
-
China Meheco Group Co Ltd
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
China
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Providers & Services
Sub-sector
Health Care
Capitalization (millions of $)
6100.2
Ticker
0874.HK
ISIN
CNE100000387
IPO date
1997-10-21
Availability on Russian exchanges
No
Reporting for
2024-03-15
Date fact. publication of reports
2023-12-31
Company Description
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd i is engaged in the pharmaceutical and healthcare industry. The Company's segments are Great Southern TCM, Great Commerce, Great Health and Great Medical Care. The Company's Great South TCM includes research, development, manufacturing and sales for Chinese and western medicine, chemical raw medicine, natural drug, biological medicine and intermediates of chemical raw medicine. The Company's Great Health segment includes the research, development, manufacturing and sales of beverages, foods, health products and other products. The Company's Great Commerce segment includes wholesale, retail, import and export for western medicine, Chinese medicine and medical apparatus and instruments. The Great Medical segment is engaged in medical services, traditional Chinese medicine health preservation, modern pension and medical equipment industry.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: